Skip to main content
. 2013 Aug 30;30(1):1–27. doi: 10.1002/cnm.2584

Figure 7.

Figure 7

Study of the sensitivity of the model-predicted bone matrix volume fraction fbm after 10 years of postmenopausal osteoporosis progress with respect to a varying anabolic strength parameter λ, computed for an administration regime involving multiple administrations of denosumab, with a constant administration interval Δtden = 9 months and administered doses Dden = 0, Inline graphicmg/kg, Inline graphic mg/kg, and Inline graphic mg/kg.